The SM Journey: Sharing
Explore insights and strategies for managing the disease long-term.
-
-
Increased ST2 levels may be a biomarker of SM, study suggests
-
FDA accepts New Drug Application for bezuclastinib in nonadvanced SM
-
What is the histamine bucket theory?
-
New treatment approach for osteoporosis in SM shows promise
-
New review explores connection between hereditary alpha-tryptasemia and SM
-
My experience at Rare Disease Week on Capitol Hill
